Med. praxi. 2017;14(4):199-202 [Interní Med. 2017; 19(2): 85-87]

Tick-borne encephalitis – a disease with variable outcome

MUDr. Martina Pýchová1, prof. MUDr. Petr Husa, CSc.1, MUDr. Lenka Fašaneková1, MUDr. Radana Pařízková1, MUDr. Michaela Freibergerová1, MUDr. Martin Slezák2
1 Klinika infekčních chorob Fakultní nemocnice Brno a LF MU Brno
2 Klinika anesteziologie, resuscitace a intenzivní medicíny Fakultní nemocnice Brno a LF MU Brno

A tick is one of the most important vectors of infectious diseases worldwide. Tick-borne encephalitis (TBE) is one of them. TheCzech Republic belongs among countries with the highest occurrence of the disease. Clinical presentation and relevance arevariable – from asymptomatic or abortive forms to classical neurological manifestation such as meningitis, encephalitis, meningoencephalomyelitiseven death. Complications are more often seen in elderly people and consequences of the disease(post-encephalitic syndrome, palsies) can be permanent. Specific treatment still does not exist and vaccination is the only effectiveprotection against TBE.

Keywords: tick-borne encephalitis, complications, consequences, prevention

Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pýchová M, Husa P, Fašaneková L, Pařízková R, Freibergerová M, Slezák M. Tick-borne encephalitis – a disease with variable outcome. Med. praxi. 2017;14(4):199-202.
Download citation

References

  1. Gritsun T, Lashkevich V, Gould E. Tick-borne encephalitis. Viral Bioterrorism Biodefence. 2003; 57(1-2): 129-146. doi:10.1016/S0166-3542(02)00206-1. Go to original source... Go to PubMed...
  2. Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin Infect Dis. 1999; 28(4): 882-890. doi:10.1086/515195. Go to original source... Go to PubMed...
  3. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. New York: Churchill Livingstone; 2010.
  4. de Graaf JA, Reimerink JHJ, Voorn GP, et al. First human case of tick-borne encephalitis virus infection acquired in the Netherlands, July 2016. Eurosurveillance. 2016; 21(33). doi:10.2807/1560-7917.ES.2016.21.33.30318. Go to original source... Go to PubMed...
  5. Česká vakcinologická společnost: Doporučený postup České vakcinologické společnosti pro prevenci a očkování proti klíšťové encefalitidě. 2016
  6. Kříž B, Gašpárek M, Šebestová H. Situace ve výskytu klíšťové encefalitidy do roku 2014 v České republice. http://www.szu.cz/tema/prevence/klistova-encefalitida.
  7. Labuda M, Elecková E, Licková M, Sabó A. Tick-borne encephalitis virus foci in Slovakia. Int J Med Microbiol IJMM. 2002; 291(Suppl 33): 43-47. Go to original source...
  8. Bogovic P, Lotric-Furlan S, Strle F. What tick-borne encephalitis may look like: clinical signs and symptoms. Travel Med Infect Dis. 2010; 8(4): 246-250. doi:10.1016/j.tmaid.2010.05.011. Go to original source... Go to PubMed...
  9. Logar M, Arnez M, Kolbl J, Avsic-Zupanc T, Strle F. Comparison of the epidemiological and clinical features of tick-borne encephalitis in children and adults. Infection. 2000; 28(2): 74-77. Go to original source... Go to PubMed...
  10. Kaiser R. Tick-borne encephalitis: Clinical findings and prognosis in adults. Wien Med Wochenschr. 2012; 162(11-12): 239-243. doi:10.1007/s10354-012-0105-0. Go to original source... Go to PubMed...
  11. Lindquist L, Vapalahti O. Tick-borne encephalitis. The Lancet. 2008; 371(9627): 1861-1871. doi:10.1016/S0140-6736(08)60800-4. Go to original source... Go to PubMed...
  12. Mickiene A, Laiskonis A, Günther G, Vene S, Lundkvist A, Lindquist L. Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2002; 35(6): 650-658. doi:10.1086/342059. Go to original source... Go to PubMed...
  13. Günther G, Haglund M, Lindquist L, Forsgren M, Sköldenberg B. Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J Neurol. 1997; 244(4): 230-238. Go to original source... Go to PubMed...
  14. Jelinek T. TBE-update on vaccination recommendations for children, adolescents, and adults. Wien Med Wochenschr. 2012; 162(11-12): 248-251. doi:10.1007/s10354-012-0112-1. Go to original source... Go to PubMed...
  15. Süss J, Kahl O, Aspöck H, et al. Tick-borne encephalitis in the age of general mobility. Wien Med Wochenschr 1946. 2010; 160(3-4): 94-100. doi:10.1007/s10354-010-0756-7. Go to original source... Go to PubMed...
  16. Lenhard T, Ott D, Jakob NJ, et al. Predictors, Neuroimaging Characteristics and Long-Term Outcome of Severe European Tick-Borne Encephalitis: A Prospective Cohort Study. PLoS ONE. 2016; 11(4). doi:10.1371/journal.pone.0154143. Go to original source...
  17. Smíšková D, Džupová O, Pícha D. Těžký průběh klíšťové meningoencefalitidy - je věk jediným faktorem, který nepříznivě ovlivňuje prognózu pacientů? Vakcinologie. 2013; 7(3): 130-134.
  18. Jereb M, Karner P, Muzlovic I, Jurca T. Severe tick-borne encephalitis in Slovenia in the years 2001-2005: time for a mass vaccination campaign? Wien Klin Wochenschr. 2006; 118(23-24): 765-768. doi:10.1007/s00508-006-0728-5. Go to original source... Go to PubMed...
  19. Pýchová M. Možné Rizikové Faktory Komplikovaného Průběhu Klíšťové Encefalitidy. Vol 2014. Brno: Masarykova univerzita, Lékařská fakutla, Klinika infekčních chorob; 2014.
  20. Waldvogel K, Bossart W, Huisman T, Boltshauser E, Nadal D. Severe tick-borne encephalitis following passive immunization. Eur J Pediatr. 1996; 155(9): 775-779. Go to original source... Go to PubMed...
  21. Růžek D. Patogeneze klíšťové encefalitidy a možnosti antivirové terapie. Epidemiol Mikrobiol Imunol Cas Spolecnosti Epidemiol Mikrobiol Ceske Lek Spolecnosti JE Purkyne. 2015; 64(4): 204-209.
  22. Atrasheuskaya AV, Fredeking TM, Ignatyev GM. Changes in immune parameters and their correction in human cases of tick-borne encephalitis. Clin Exp Immunol. 2003; 131(1): 148-154. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.